In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
All content for On Medical Grounds is the property of Medavera and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
A Pharmacist’s Take: Navigating the Diabetes Drug Shortage – Part 1
On Medical Grounds
26 minutes
1 year ago
A Pharmacist’s Take: Navigating the Diabetes Drug Shortage – Part 1
Today On Medical Grounds, we will be speaking with Dr. Heather Whitley. Dr. Whitley is a clinical professor in the Department of Pharmacy Practice at the Auburn University Harrison College of Pharmacy. She is a board certified pharmacotherapy specialist and a certified diabetes educator. Earlier this year, Dr. Whitley spoke with us about screening for diabetes in high-risk individuals. Today, she is back to talk about some new things going on in the diabetes and pharmacy world. This is ...
On Medical Grounds
In part 2 of our discussion on Alzheimer's diagnostics, our host, Jane Caldwell, speaks with Dr. Francesca De Simone. Dr. De Simone is Scientific Affairs Manager for Fujirebio Diagnostics and leads the company's neurodegenerative disease program. Dr. De Simone discusses the role of blood-based biomarkers for Alzheimer's disease in comparison to other forms of diagnostic tests, as well as her insights on the clinical needs for Alzheimer's and current progress in the field. Educational su...
